vitro conditions, according to Trager and Jensen,51 (link) in RPMI 1640 medium containing 20 mM HEPES (N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic
acid), 32 mM NaHCO3, and 10% heat-activated human serum
with 3% erythrocytes in a humidified 37 °C incubator with 3%
CO2. The culture was passaged with a fresh mixture of erythrocytes
and medium every day to maintain cell growth. Quantitative assessment
of antimalarial activity in vitro was determined
by microculture radioisotope techniques based upon the methods described
by Desjardins et al.52 (link) Briefly, a mixture
of 200 μL of 1.5% erythrocytes with 1% parasitemia at the early
ring stage was pre-exposed to 25 μL of the medium containing
a test sample dissolved in 1% DMSO (0.1% final concentration) for
24 h. Subsequently, 25 μL of [3H] hypoxanthine (Amersham,
USA) in culture medium (0.5 μCi) was added to each well and
the plates were incubated for an additional 24 h. Levels of incorporated
radioactive-labeled hypoxanthine, indicating parasite growth, were
determined using a Top Count microplate scintillation counter (Packard,
USA). The percentage of parasite growth was calculated using the signal
count per minute of treated (CPMT) and untreated conditions (CPMU)
as shown by